IMPACT NEWS
Spotlight on health pioneers
discover the newest testimonial film from our start-up community
SEITO Biologics
Tackling autoimmunity with selective Treg cell engagers
SEITO Biologics (SEITO) develops a novel and transformative immunotherapy targeting the root causes of autoimmune diseases. By selectively stimulating Treg cells to restore immune balance, SEITO aims to achieve long-term remission, reduce complications, and ultimately provide curative treatments.
